Skip to content
GLP-1 Desk
Menu
Dispatch #66

Navio MD

NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).

Visit Navio MDAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$345/mo (starting dose, brand-name)
Tirzepatide
$189/mo (starting dose, compounded)
Coverage
48 states
Brand-name
Yes

Line Navio MD up against its closest alternatives. Or go one-on-one: Navio MD vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access78/100
Molecule range79/100
Onboarding speed75/100
Support responsiveness83/100
Licensing & trust88/100

What the Desk likes

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

Where points come off

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases

The Desk's briefing — C+

Best for: Readers who want compounded tirzepatide with brand-name fallback across 48 states.

Navio MD ranks #66 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (20)

Pricing and verification reflect Navio MD's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Navio MD's site. Not medical advice; see our disclosure.

← Back to The Desk